Value
7.9/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 7.8 |
| P/S | 9.9 |
| EV/EBITDA | 6.9 |
| Fwd P/E | 9.1 |
| PEG | 9.8 |
| Analyst target | 4.0 |
- ▸Forward P/E: 11.2x
- ▸PEG: 0.54
- ▸Attractively valued
CPB · Why this verdict
Why The Campbell's (CPB) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score4.3/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
The Campbell's Company offers an attractively priced consumer staples business with three recent earnings beats, but revenue is declining at 4%, short interest is at an extraordinary 32%, the stock is overbought after a bear-market rally, and the near-term risk/reward is deeply unfavorable — a combination that warrants caution rather than commitment.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Revenue is declining at 4% annually — one of the weaker growth profiles in the packaged-foods peer group, ranking near the bottom of the industry growth rankings — suggesting the core business is losing volume or pricing power at a rate that cost discipline cannot sustainably offset. Growth breakdown | Revenue growth turns positive on a year-over-year basis for 2 consecutive quarters, validating that the volume decline is cyclical and has found a floor. | →Stable |
| CounterDespite the top-line decline, the company has beaten earnings estimates in 3 of the last 4 quarters through cost management, demonstrating that margins can protect profitability even as revenue contracts in the near term. | ||
The RSI has reached 77 — technically overbought — while the stock remains below its 200-day moving average in a confirmed downtrend with the slope declining at 5.4% over 30 days; a configuration historically associated with bear-market rallies that fade rather than develop into durable recoveries. Momentum breakdown | A sustainable recovery would require RSI to normalize below 70, price to hold above nearby support, and the stock to eventually reclaim the 200-day moving average on improving volume. | →Stable |
| CounterRising on-balance volume and an improving MACD suggest that buying demand is genuine and not purely short-covering; the momentum score recovering to 6.1 from the death-cross low is a meaningful positive data point within the broader downtrend. | ||
A short interest of 32% represents an extraordinary level of institutional skepticism for a consumer staples company — an overhang that creates persistent price suppression and signals the professional investment community remains deeply unconvinced by the current rally. Risk breakdown | Short interest falls below 15% over 4 consecutive weeks as shorts cover, providing structural relief from the supply overhang and signaling a shift in institutional positioning. | ↑Improving |
| CounterExtreme short interest can function as a powerful contrarian catalyst — if earnings continue to beat, short-covering can amplify gains materially beyond what fundamentals alone would imply, turning the overhang into an accelerant. | ||
With only 2.1% upside to the technical target and a risk/reward ratio of 0.31-to-1, the current price geometry offers deeply asymmetric risk — the realistic downside substantially exceeds the near-term gain available, making new entry indefensible at present levels. Price targets | A better setup would emerge if the stock pulls back enough to restore upside beyond 10%, rebuilding a risk/reward ratio above 1.5-to-1 before new capital is committed. | →Stable |
| CounterThe strong recent beat streak and recovering momentum suggest the market is willing to rerate a consumer defensive above traditional resistance; the current geometry may reflect a transition to a higher-priced equilibrium rather than an overextension. | ||
Revenue is declining at 4% annually — one of the weaker growth profiles in the packaged-foods peer group, ranking near the bottom of the industry growth rankings — suggesting the core business is losing volume or pricing power at a rate that cost discipline cannot sustainably offset.
→StableGrowth breakdown
- Expectation
- Revenue growth turns positive on a year-over-year basis for 2 consecutive quarters, validating that the volume decline is cyclical and has found a floor.
CounterDespite the top-line decline, the company has beaten earnings estimates in 3 of the last 4 quarters through cost management, demonstrating that margins can protect profitability even as revenue contracts in the near term.
The RSI has reached 77 — technically overbought — while the stock remains below its 200-day moving average in a confirmed downtrend with the slope declining at 5.4% over 30 days; a configuration historically associated with bear-market rallies that fade rather than develop into durable recoveries.
→StableMomentum breakdown
- Expectation
- A sustainable recovery would require RSI to normalize below 70, price to hold above nearby support, and the stock to eventually reclaim the 200-day moving average on improving volume.
CounterRising on-balance volume and an improving MACD suggest that buying demand is genuine and not purely short-covering; the momentum score recovering to 6.1 from the death-cross low is a meaningful positive data point within the broader downtrend.
A short interest of 32% represents an extraordinary level of institutional skepticism for a consumer staples company — an overhang that creates persistent price suppression and signals the professional investment community remains deeply unconvinced by the current rally.
↑ImprovingRisk breakdown
- Expectation
- Short interest falls below 15% over 4 consecutive weeks as shorts cover, providing structural relief from the supply overhang and signaling a shift in institutional positioning.
CounterExtreme short interest can function as a powerful contrarian catalyst — if earnings continue to beat, short-covering can amplify gains materially beyond what fundamentals alone would imply, turning the overhang into an accelerant.
With only 2.1% upside to the technical target and a risk/reward ratio of 0.31-to-1, the current price geometry offers deeply asymmetric risk — the realistic downside substantially exceeds the near-term gain available, making new entry indefensible at present levels.
→StablePrice targets
- Expectation
- A better setup would emerge if the stock pulls back enough to restore upside beyond 10%, rebuilding a risk/reward ratio above 1.5-to-1 before new capital is committed.
CounterThe strong recent beat streak and recovering momentum suggest the market is willing to rerate a consumer defensive above traditional resistance; the current geometry may reflect a transition to a higher-priced equilibrium rather than an overextension.
Per-dimension breakdown
Quality
3.9/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 3.4 |
| ROA | 3.3 |
| Gross margin | 1.7 |
| Op margin | 4.1 |
| Net margin | 2.1 |
| Current ratio | 3.3 |
| FCF quality | 10.0 |
| Moat | 3.1 |
| Piotroski F | 4.4 |
- ▸Excellent cash conversion: 157% FCF/NI
- ▸No competitive moat
Growth
0.5/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 0.5 |
- ▸Declining revenue: -8%
Momentum
3.8/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.8 |
| MACD | 10.0 |
| OBV | 1.0 |
| MA position | 4.0 |
| Volume | 0.0 |
- ▸Volume distribution (falling OBV)
- ▸Below 200-MA, MA slope -4.5%/30d — confirmed downtrend
Sentiment
5.2/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 5.5 |
| Analyst rating | 5.0 |
| Price target | 5.1 |
Insider
5.8/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 7.5 |
| notable moves | 5.0 |
- ▸No net insider activity — $0 (0.000% of mkt cap)
Peer rank
3.4/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 4.8 |
| quality rank | 5.5 |
| growth rank | 1.3 |
Technical
2.5/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 1.9 |
| support resistance | 2.6 |
| 52w position | 3.1 |
Risk (lower is worse)
5.3/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 0.0 |
| days to cover | 5.7 |
| volatility | 4.6 |
| put call | 8.4 |
| implied vol | 4.9 |
| beta | 10.0 |
| debt equity | 3.4 |
- ▸High short interest: 25%
- ▸Concentration risks: 1 HIGH, 1 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
4.8/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 5.6 |
| earnings timing | 5.0 |
| surprise avg | 2.4 |
| dividend safety | 5.8 |
| news activity | 5.0 |
- ▸Dividend: 4.9%
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCK:QUALITY_FLOORPassed (6)
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:40d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (3)
- MOMENTUM:3.8<4.5
- ASYMMETRY:-0.9=NEGATIVE
- DEATH_CROSS:HARD_BLOCK
Warning (0)
none
Reward-to-Risk
-0.94
Upside
-9.1%
Downside
9.7%
Sizing output
AVOID
SetupRecovery — Death cross but MACD improving, RSI 62
EdgeNo clear edge — No clear edge identified
SuitabilityModerate — Balanced profile
Investment implication
The SELL_IF_HOLDING verdict reflects the MOMENTUM gate's 3.8<4.5 outcome against Value at 7.9 and asymmetric R:R of -0.94.
The strongest dimensions are Value at 7.9, Insider at 5.8, and Risk (lower is worse) at 5.3; the weakest are Growth at 0.5, Technical at 2.5, and Peer rank at 3.4. The V9 engine flagged 3 failed gates, producing an asymmetric reward-to-risk of -0.94 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Overbought Bear Rally On Downtrend
Trip ifPrice reclaims and holds above the 200-day moving average for 4 consecutive weeks with RSI normalizing below 65, falsifying the bear-rally-on-downtrend thesis.
- P2Revenue Decline Eroding Operating Base
Trip ifRevenue growth turns positive above 0% year-over-year for 2 consecutive reported quarters.
- P332 Pct Short Interest Structural Overhang
Trip ifShort interest falls below 15% over 4 consecutive weeks as institutional shorts cover.
- P4Unfavorable Risk Reward At Resistance
Trip ifUpside to technical target expands beyond 10% through a pullback or target revision, restoring risk/reward above 1.5-to-1.